{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-26-000007","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.688239+00:00","generated_at":"2026-05-15T15:32:33.953541+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Exagen reports record FY 2025 revenue of $66.6M, up 20% YoY; guides FY 2026 revenue $70-73M","bullets":["Full-year 2025 revenue $66.6M (+20% YoY); Q4 2025 revenue $16.6M.","Full-year net loss $19.95M; adjusted EBITDA loss $9.79M; gross margin 58.3%.","AVISE CTD test volume grew >11% YoY; trailing 12-month ASP rose to $441 (+7%).","FY 2026 revenue guidance of $70M to $73M; path to cash flow positivity.","Year-end cash $32.4M; strengthened by $20M equity offering and $25M credit facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-26-000007","json":"https://secwatch.observer/filing/0001274737-26-000007.json","markdown":"https://secwatch.observer/filing/0001274737-26-000007.md","text":"https://secwatch.observer/filing/0001274737-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473726000007/0001274737-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473726000007/exdx-20260310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T15:32:33.953541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}